Compare
Guardian Pharmacy Services, Inc. vs PetMed Express Inc vs Ridgetech Inc. vs CVS Health Corp
| Latest fiscal year | Guardian Pharmacy Services, Inc. GRDN | PetMed Express Inc PETS | Ridgetech Inc. RDGT | CVS Health Corp CVS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-03-31 | 2026-03-31 | 2025-12-31 |
| Revenue | $1.45B | $179.02M | $132.16M | $402.07B |
| Revenue growth (YoY) | +17.9% | -21.1% | +10.2% | +7.8% |
| Gross margin | 20.2% | 28.1% | 3.6% | n/a |
| Operating margin | 5.0% | -32.8% | -1.4% | 1.2% |
| Net margin | 3.4% | -32.0% | -0.9% | 0.4% |
| Net income | $49.22M | -$57.29M | -$1.25M | $1.73B |
| EPS (Diluted) | n/a | -$2.74 | -$17.21 | $1.39 |
| Operating cash flow | $100.25M | -$28.39M | -$1.39M | $10.64B |
| Free cash flow | $86.84M | -$33.01M | -$1.39M | $7.81B |
| Cash & equivalents | $65.62M | $21.41M | $17.91M | $8.45B |
| Total assets | $412.66M | $81.19M | $69.03M | $253.54B |
| Total liabilities | $194.73M | $52.25M | $28.25M | $178.16B |
| Shareholders' equity | $217.92M | $28.94M | $40.78M | $75.21B |
| Return on year-end equity | 22.6% | -197.9% | -3.1% | 2.3% |
| Shares outstanding | n/a | 21.39M | 887.3K | 1.27B |
Revenue, most recent five fiscal years
| Fiscal year | Guardian Pharmacy Services, Inc. | PetMed Express Inc | Ridgetech Inc. | CVS Health Corp |
|---|---|---|---|---|
| Latest | $1.45B Ended 2025-12-31 | $179.02M Ended 2026-03-31 | $132.16M Ended 2026-03-31 | $402.07B Ended 2025-12-31 |
| 1 year earlier | $1.23B Ended 2024-12-31 | $226.97M Ended 2025-03-31 | $119.97M Ended 2025-03-31 | $372.81B Ended 2024-12-31 |
| 2 years earlier | n/a | $274.10M Ended 2024-03-31 | $123.99M Ended 2024-03-31 | $357.78B Ended 2023-12-31 |
| 3 years earlier | n/a | $247.57M Ended 2023-03-31 | $120.20M Ended 2023-03-31 | $322.47B Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $164.39M Ended 2022-03-31 | $292.11B Ended 2021-12-31 |